Market revenue in 2023 | USD 0.1 million |
Market revenue in 2030 | USD 0.1 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical decision support system solutions |
Fastest growing segment | Computerized Physician Order Entry |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Computerized Physician Order Entry, Clinical Decision Support System Solutions, Other Software |
Key market players worldwide | Becton Dickinson & Co, GE HealthCare Technologies Inc Common Stock, McKesson Corp, Oracle Corp, Omnicell Inc, Hyland, Talyst, QuadraMed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medication management system market will help companies and investors design strategic landscapes.
Clinical decision support system solutions was the largest segment with a revenue share of 0% in 2023. Horizon Databook has segmented the China medication management system market based on computerized physician order entry, clinical decision support system solutions, other software covering the revenue growth of each sub-segment from 2018 to 2030.
Growing healthcare expenditure & infrastructure, large elderly population; increasing number of reforms & initiatives being undertaken by governments to enhance IT infrastructure in hospitals; and presence of a large number of local players offering competitive solutions in the healthcare industry are some of the factors responsible for the high growth of China medication management market during the forecast period.
According to the American Cancer Society, nearly 4.3 million new cancer cases are reported in China each year. This number has increased from 3.07 million in 2012 (WHO).
This is likely to increase the number of people seeking treatment for cancer and thereby the number of prescriptions per year. Increasing number of prescriptions can be managed using medication management software.
Horizon Databook provides a detailed overview of country-level data and insights on the China medication management system market , including forecasts for subscribers. This country databook contains high-level insights into China medication management system market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account